Lemierre's syndrome: new insights into an old disease.
Stallworth
J R
JR
Pediatrics Department, University of South Carolina School of Medicine, Columbia, USA.
Carroll
J M
JM
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005674:Fusobacterium Infections / Q000175:diagnosis*; D005675:Fusobacterium necrophorum / Q000302:isolation & purification; D006801:Humans; D007674:Kidney Diseases / Q000175:diagnosis / Q000382:microbiology*; D008100:Liver Abscess / Q000175:diagnosis*; D008171:Lung Diseases / Q000175:diagnosis / Q000382:microbiology*; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D009254:Nafcillin / Q000008:administration & dosage / Q000627:therapeutic use; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D018805:Sepsis / Q000175:diagnosis; D013577:Syndrome
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D008795:Metronidazole; D009254:Nafcillin; D002443:Ceftriaxone